Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 5:32 pm Purchase | 2025-08-11 | 13G | MEI Pharma, Inc. MEIP | Alexander Schornstein | 2,115,000 6.530% | 2,115,000 (New Position) | Filing History |
| 2025-07-29 5:23 pm Purchase | 2025-07-22 | 13G | MEI Pharma, Inc. MEIP | Citadel Advisors LLC | 3,245,888 9.990% | 3,245,888 (New Position) | Filing History |
| 2025-07-24 3:53 pm Unchanged | 2025-07-22 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 3.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | MEI Pharma, Inc. MEIP | TANG CAPITAL PARTNERS LP | 326,084 4.900% | -35,000 (-9.69%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | MEI Pharma, Inc. MEIP | VANGUARD GROUP INC | 389,807 5.850% | 389,807 (New Position) | Filing History |
| 2023-11-01 5:20 pm Unchanged | 2023-10-31 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 16.400% | 0 (Unchanged) | Filing History |
| 2023-10-24 5:00 pm Purchase | 2023-10-20 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 16.400% | 179,000 (+19.58%) | Filing History |
| 2023-10-13 5:00 pm Purchase | 2023-10-11 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 914,188 13.700% | 50,000 (+5.79%) | Filing History |
| 2023-09-26 5:19 pm Purchase | 2023-09-22 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 864,188 13.000% | 48,060 (+5.89%) | Filing History |
| 2023-09-22 5:21 pm Purchase | 2023-09-20 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 816,128 12.200% | 153,600 (+23.18%) | Filing History |
| 2023-09-15 5:29 pm Unchanged | 2023-09-13 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-08-08 4:41 pm Unchanged | 2023-08-04 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-07-17 4:34 pm Unchanged | 2023-07-17 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-05-30 4:57 pm Purchase | 2023-05-19 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 131,630 (+24.79%) | Filing History |
| 2023-05-01 4:00 pm Purchase | 2023-04-20 | 13G | MEI Pharma, Inc. MEIP | TANG CAPITAL PARTNERS LP | 361,084 5.400% | 361,084 (New Position) | Filing History |
| 2023-03-09 4:10 pm Sale | 2023-03-09 | 13D | MEI Pharma, Inc. MEIP | Growth Equity Opportunities V LLC | 1 5.000% | -498,160 (-100.00%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 530,898 8.000% | 506,550 (+2080.42%) | Filing History |
| 2023-02-09 4:04 pm Sale | 2022-12-31 | 13G | MEI Pharma, Inc. MEIP | UBS Oncology Impact Fund L.P. | 0 0.000% | -506,893 (Position Closed) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | MEI Pharma, Inc. MEIP | VANGUARD GROUP INC | 383,551 5.760% | 383,551 (New Position) | Filing History |
| 2022-05-31 4:55 pm Sale | 2022-05-31 | 13G | MEI Pharma, Inc. MEIP | First Light Asset Management LLC | 800 0.010% | -578,886 (-99.86%) | Filing History |